ProQuest Associates IV LLC, 10% Owner at Immune Design Corp. (IMDZ), bought 696,941 shares at $12.00 ($4.7M) on 2014-07-29, disclosed to the SEC on 2014-07-31.
Open-market purchase of $4.7M IMDZ by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 305,810 | $0 | 0.0% |
| 2 | $12.00 | 391,131 | $4.7M | 100.0% |
| Total | $6.73 avg | 696,941 | $4.7M | 100% |
| Filing → |
| EGRX | SELL | 2017-01-06 | $11.1M | — | Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |